Carmat Expands Its PIVOTAL Study Internationally, In Line With Its Clinical Strategy And CE Marking Process Post author:Sam Post published:October 5, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Rigel Pharma Awaits FDA Approval for Tavalisse, Builds Commercial Org for Drug Launch January 14, 2018 4 Biotechs That Could Release Stock-Shattering Data Soon May 9, 2017 Rumored Acquisition Target Bristol-Myers Squibb Names 3 New Directors, Plans $2 Billion Accelerated Share Buyback February 20, 2017
Rigel Pharma Awaits FDA Approval for Tavalisse, Builds Commercial Org for Drug Launch January 14, 2018
Rumored Acquisition Target Bristol-Myers Squibb Names 3 New Directors, Plans $2 Billion Accelerated Share Buyback February 20, 2017